Login Register Cart 0
Generic placeholder image

Current Proteomics

Editor-in-Chief

ISSN (Print): 1570-1646
ISSN (Online): 1875-6247

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

RNA Sequencing of A2780 Cells Treated with CCL2 Identified Genes Associated with A2780 Cell Growth

Author(s): Zhenling Ma*, Lei Wang, Kun Cheng, Guozhen Xing, Jiajia Zhang and Wei Liu

Volume 20, Issue 2, 2023

Published on: 20 October, 2023

Page: [128 - 135] Pages: 8

DOI: 10.2174/0115701646256131231013111220

Price: $65

Abstract

Introduction: Ovarian cancer is a common gynecological malignancy. It is one of the leading causes of death among women worldwide. The incidence of ovarian cancer ranks third, and mortality is the first among gynecological malignant tumors. CCL2 (Chemokine C-C motif Ligand 2) is associated with the progression of a variety of tumors, including ovarian cancer. However, the mechanism of CCL2 in A2780 cell growth has not been clarified.

Method: In this study, we found that exogenous CCL2 promoted A2780 cell activity. RNA sequencing was used to identify the transcriptomic changes in CCL2-treated A2780 cells. Based on a p-value less than 0.05 and |log2 Fold Change| greater than 1, 190 differentially expressed genes were selected. Of these genes, 82 were observed to be upregulated and 108 downregulated.

Result: The GO (gene ontology) analysis of differentially expressed genes was used to identify the underlying functions and biological processes. In addition, the expression of the topmost upregulated genes was verified by qPCR.

Conclusion: This work may provide new markers and reveal the underlying mechanism of exogenous CCL2 in A2780 cell proliferation.

« Previous Next »
Graphical Abstract

[1]
Doherty, J.A.; Peres, L.C.; Wang, C.; Way, G.P.; Greene, C.S.; Schildkraut, J.M. Challenges and opportunities in studying the epidemiology of ovarian cancer subtypes. Curr. Epidemiol. Rep., 2017, 4(3), 211-220.
[http://dx.doi.org/10.1007/s40471-017-0115-y] [PMID: 29226065]
[2]
Lheureux, S.; Gourley, C.; Vergote, I.; Oza, A.M. Epithelial ovarian cancer. Lancet, 2019, 393(10177), 1240-1253.
[http://dx.doi.org/10.1016/S0140-6736(18)32552-2] [PMID: 30910306]
[3]
Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71(3), 209-249.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[4]
Jayson, G.C.; Kohn, E.C.; Kitchener, H.C.; Ledermann, J.A. Ovarian cancer. Lancet, 2014, 384(9951), 1376-1388.
[http://dx.doi.org/10.1016/S0140-6736(13)62146-7] [PMID: 24767708]
[5]
Stewart, C.; Ralyea, C.; Lockwood, S. Ovarian cancer: An integrated review. Semin. Oncol. Nurs., 2019, 35(2), 151-156.
[http://dx.doi.org/10.1016/j.soncn.2019.02.001] [PMID: 30867104]
[6]
Gloss, B.S.; Samimi, G. Epigenetic biomarkers in epithelial ovarian cancer. Cancer Lett., 2014, 342(2), 257-263.
[http://dx.doi.org/10.1016/j.canlet.2011.12.036] [PMID: 22245949]
[7]
Furukawa, S.; Soeda, S.; Kiko, Y.; Suzuki, O.; Hashimoto, Y.; Watanabe, T.; Nishiyama, H.; Tasaki, K.; Hojo, H.; Abe, M.; Fujimori, K. MCP-1 promotes invasion and adhesion of human ovarian cancer cells. Anticancer Res., 2013, 33(11), 4785-4790.
[PMID: 24222114]
[8]
Deng, W.; Gu, X.; Lu, Y.; Gu, C.; Zheng, Y.; Zhang, Z.; Chen, L.; Yao, Z.; Li, L.Y. Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization. Angiogenesis, 2012, 15(1), 71-85.
[http://dx.doi.org/10.1007/s10456-011-9244-y] [PMID: 22210436]
[9]
Pasquier, J.; Gosset, M.; Geyl, C.; Hoarau-Véchot, J.; Chevrot, A.; Pocard, M.; Mirshahi, M.; Lis, R.; Rafii, A.; Touboul, C. CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer. Mol. Cancer, 2018, 17(1), 47.
[http://dx.doi.org/10.1186/s12943-018-0787-z] [PMID: 29455640]
[10]
Yasui, H.; Kajiyama, H.; Tamauchi, S.; Suzuki, S.; Peng, Y.; Yoshikawa, N.; Sugiyama, M.; Nakamura, K.; Kikkawa, F. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway. Clin. Exp. Metastasis, 2020, 37(1), 145-158.
[http://dx.doi.org/10.1007/s10585-019-09993-y] [PMID: 31541326]
[11]
Liu, W.; Wang, L.; Zhang, J.; Qiao, L.; Liu, Y.; Yang, X.; Zhang, J.; Zheng, W.; Ma, Z. Purification of recombinant human chemokine CCL2 in E. coli and its function in ovarian cancer. 3 Biotech, 2021, 11(1), 8.
[12]
Ran, M.; Chen, B.; Li, Z.; Wu, M.; Liu, X.; He, C.; Zhang, S.; Li, Z. Systematic identification of long noncoding RNAs in immature and mature porcine testes. Biol. Reprod., 2016, 94(4), 77.
[http://dx.doi.org/10.1095/biolreprod.115.136911] [PMID: 26935596]
[13]
Shu, J.; Liu, Z.; Jin, L.; Wang, H. An RNA sequencing study identifies candidate genes for angiotensin II induced cardiac remodeling. Mol. Med. Rep., 2018, 17(1), 1954-1962.
[PMID: 29138860]
[14]
Trapnell, C.; Williams, B.A.; Pertea, G.; Mortazavi, A.; Kwan, G.; van Baren, M.J.; Salzberg, S.L.; Wold, B.J.; Pachter, L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol., 2010, 28(5), 511-515.
[http://dx.doi.org/10.1038/nbt.1621] [PMID: 20436464]
[15]
Wang, L.; Feng, Z.; Wang, X.; Wang, X.; Zhang, X. DEGseq: An R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics, 2010, 26(1), 136-138.
[http://dx.doi.org/10.1093/bioinformatics/btp612] [PMID: 19855105]
[16]
Tian, T.; Liu, Y.; Yan, H.; You, Q.; Yi, X.; Du, Z.; Xu, W.; Su, Z. agriGO v2.0: A GO analysis toolkit for the agricultural community, 2017 update. Nucleic Acids Res., 2017, 45(W1), W122-W129.
[http://dx.doi.org/10.1093/nar/gkx382] [PMID: 28472432]
[17]
Viscarra, T.; Buchegger, K.; Jofre, I.; Riquelme, I.; Zanella, L.; Abanto, M.; Parker, A.C.; Piccolo, S.R.; Roa, J.C.; Ili, C.; Brebi, P. Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line. Biol. Res., 2019, 52(1), 13.
[http://dx.doi.org/10.1186/s40659-019-0220-0] [PMID: 30894224]
[18]
Hefler, L.; Tempfer, C.; Heinze, G.; Mayerhofer, K.; Breitenecker, G.; Leodolter, S.; Reinthaller, A.; Kainz, C. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br. J. Cancer, 1999, 81(5), 855-859.
[http://dx.doi.org/10.1038/sj.bjc.6690776] [PMID: 10555758]
[19]
Sun, C.; Li, X.; Guo, E.; Li, N.; Zhou, B.; Lu, H.; Huang, J.; Xia, M.; Shan, W.; Wang, B.; Li, K.; Weng, D.; Xu, X.; Gao, Q.; Wang, S.; Hu, J.; Lu, Y.; Mills, G.B.; Chen, G. MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis. Oncogene, 2020, 39(8), 1681-1695.
[http://dx.doi.org/10.1038/s41388-019-1090-1] [PMID: 31705064]
[20]
Maakaron, J.E.; Rogosheske, J.; Long, M.; Bachanova, V.; Mims, A.S. CD33-targeted therapies: Beating the disease or beaten to death? J. Clin. Pharmacol., 2021, 61(1), 7-17.
[http://dx.doi.org/10.1002/jcph.1730] [PMID: 32875599]
[21]
O’Sullivan, J.; Bitu, C.C.; Daly, S.B.; Urquhart, J.E.; Barron, M.J.; Bhaskar, S.S.; Martelli-Júnior, H.; dos Santos Neto, P.E.; Mansilla, M.A.; Murray, J.C.; Coletta, R.D.; Black, G.C.M.; Dixon, M.J. Whole-Exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndrome. Am. J. Hum. Genet., 2011, 88(5), 616-620.
[http://dx.doi.org/10.1016/j.ajhg.2011.04.005] [PMID: 21549343]
[22]
Li, L.; Saiyin, W.; Zhang, H.; Wang, S.; Xu, Q.; Qin, C.; Lu, Y. FAM20A is essential for amelogenesis, but is dispensable for dentinogenesis. J. Mol. Histol., 2019, 50(6), 581-591.
[http://dx.doi.org/10.1007/s10735-019-09851-x] [PMID: 31667691]
[23]
Yang, J.; Bogerd, H.P.; Wang, P.J.; Page, D.C.; Cullen, B.R. Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol. Cell, 2001, 8(2), 397-406.
[http://dx.doi.org/10.1016/S1097-2765(01)00303-3] [PMID: 11545741]
[24]
Jiang, J.H.; Gao, Q.; Ke, A.W.; Yu, Y.; Shi, G.M.; Fan, J.; Zhou, J.; Huang, X.W. Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinoma. Oncol. Lett., 2014, 7(3), 641-646.
[http://dx.doi.org/10.3892/ol.2014.1809] [PMID: 24520286]
[25]
Wang, G.; Li, H.; Cui, X.; Xu, T.; Dong, M.; Li, S.; Li, X. S100A1 is a potential biomarker for papillary thyroid carcinoma diagnosis and prognosis. J. Cancer, 2021, 12(19), 5760-5771.
[http://dx.doi.org/10.7150/jca.51855] [PMID: 34475990]
[26]
Xiong, T.; Pan, F.; Li, D. Expression and clinical significance of S100 family genes in patients with melanoma. Melanoma Res., 2019, 29(1), 23-29.
[http://dx.doi.org/10.1097/CMR.0000000000000512] [PMID: 30216200]
[27]
Bai, Y.; Li, L.D.; Li, J.; Lu, X. Prognostic values of S100 family members in ovarian cancer patients. BMC Cancer, 2018, 18(1), 1256.
[http://dx.doi.org/10.1186/s12885-018-5170-3] [PMID: 30558666]
[28]
DeRycke, M.S.; Andersen, J.D.; Harrington, K.M.; Pambuccian, S.E.; Kalloger, S.E.; Boylan, K.L.M.; Argenta, P.A.; Skubitz, A.P.N. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival. Am. J. Clin. Pathol., 2009, 132(6), 846-856.
[http://dx.doi.org/10.1309/AJCPTK87EMMIKPFS] [PMID: 19926575]
[29]
Yumimoto, K.; Sugiyama, S.; Mimori, K.; Nakayama, K.I. Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents. Cancer Sci., 2019, 110(7), 2090-2099.
[http://dx.doi.org/10.1111/cas.14075] [PMID: 31111571]
[30]
Yang, J.; Lv, X.; Chen, J.; Xie, C.; Xia, W.; Jiang, C.; Zeng, T.; Ye, Y.; Ke, L.; Yu, Y.; Liang, H.; Guan, X.Y.; Guo, X.; Xiang, Y. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway. Oncotarget, 2016, 7(13), 15632-15647.
[http://dx.doi.org/10.18632/oncotarget.6695] [PMID: 26701209]
[31]
Tian, D.S.; Peng, J.; Murugan, M.; Feng, L.J.; Liu, J.L.; Eyo, U.B.; Zhou, L.J.; Mogilevsky, R.; Wang, W.; Wu, L.J. Chemokine CCL2-CCR2 signaling induces neuronal cell death via STAT3 activation and IL-1β production after status epilepticus. J. Neurosci., 2017, 37(33), 7878-7892.
[http://dx.doi.org/10.1523/JNEUROSCI.0315-17.2017] [PMID: 28716963]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy